---
authors:
- admin
bio: My research interests include clinical and translational research in advanced skin cancers.
education:
  courses:
  - course: Fellowship in Hematology/Oncology
    institution: Beth Isreal Deaconess Medical Center
    year: 2015
  - course: Oncology Center for Excellence Fellowship
    institution: Food and Drug Administration
    year: 2018
  - course: Residency in Internal Medicine
    institution: Brigham and Women's Hospital
    year: 2015
  - course: Residency in Dermatology
    institution: Columbia University Medical Center
    year: 2014
  - course: Doctorate of Medicine
    institution: University of Massachusetts Medical School
    year: 2010
  - course: PhD in Biomedical Sciences
    institution: University of Massachusetts Medical School
    year: 2010
  - course: BA in Political Science
    institution: Boston College
    year: 2000
email: "dmiller4@mgh.harvard.edu"
interests:
- Clinical And Translational Research
- Advanced Skin Cancer
- Data Science
- R
name: David Michael Miller 
organizations:
- name: Massachusetts General Hospital
  url: ""
role: Medical Oncologist and Dermatologist
social:
- icon: envelope
  icon_pack: fas
  link: '#contact'
- icon: twitter
  icon_pack: fab
  link: https://twitter.com/Dave_M_Miller
- icon: google-scholar
  icon_pack: ai
  link: https://scholar.google.com/citations?user=ZS-h1PsAAAAJ&hl=enAAJ
- icon: github
  icon_pack: fab
  link: https://github.com/DM-Miller
superuser: true
user_groups:
- admin
- Principal Investigator
---

**David Michael Miller, MD, PhD, FAAD** is a Board-Certified Dermatologist and Medical Oncologist at Massachusetts General Hospital and investigator in the [**Massachusetts General Hospital Cancer Center**](https://www.massgeneral.org/cancer-center). The Miller Lab's long-term goal is to identify and develop novel therapeutics for advanced skin cancer and to understand the mechanism of response and resistance to those therapies.   

Dr. Miller graduated with Honors from Boston College where he earned a BA in Political Science.  He received his medical (MD) and PhD degree in Biomedical Sciences from the University of Massachusetts.  While at UMass, Dr. Miller received the American Diabetes Association Physician-Scientist Training Award, a Fuller Foundation grant, and he was inducted into the Alpha Omega Honor Society. 

He then completed a Dermatology residency at Columbia University Medical Center, followed by a residency in Internal Medicine at Brigham and Women's Hospital. Following both residencies, Dr. Miller completed fellowship training in Hematology/Oncology at Beth Israel Deaconess Medical Center and in the [Oncology Center of Excellence](https://www.fda.gov/about-fda/scientific-internships-fellowships-trainees-and-non-us-citizens/oncology-center-excellence-fellows-program) at the Food and Drug Administration. 

Dr. Miller is one of the very few clinicians in the country who is board certified in Internal Medicine, Dermatology and Medical Oncology. He currently practices both Dermatology and Medical Oncology in the Massachusetts General Hospital Cancer Center and at Massachusetts Eye and Ear Infirmary, where he co-directs multidiscliplinary clinics in advanced skin cancer, including the [Merkel Cell Carcinoma Treatment Program](https://www.massgeneral.org/cancer-center/treatments-and-services/melanoma/merkel-cell-carcinoma).  

Dr. Miller belongs to several professional organizations, including the American Academy of Dermatology, Medical Dermatology Society, and the American Society of Clinical Oncology.  He has numerous peer-reviewed publications and he has presented his work at the Society for Investigative Dermatology, New York Academy of Medicine, the American Academy of Dermatology, and the U.S. FDA.  He is also a reviewer for the British Journal of Dermatology, Journal of Investigative Dermatology, JAEDV, and Clinical Cancer Research.

Due to his expertise in Merkel Cell Carcinoma and Squamous Cell Carcinoma, Dr. Miller has also served on advisory boards to several pharmaceutical companies, inlcuding Pfizer, Merck, Regeneron and Sanofi Genzyme.

The Miller Lab's research portfolio consists of clinical and translational projects in [**Merkel Cell carcinoma**](https://www.merkelcellcarcinoma.io), cutaneous [**Squamous Cell Carcinoma**](https://www.squamouscellcarcinoma.io) and Melanoma.  Dr. Miller has received support for his research from the NIH in the form of a loan repayment award, a Research Grant from the American Skin Association, the Paul Carbone, MD fellowship award from ECOG-ACRIN, and the Mentoring Award in Oncology, Advanced Analytics and Regulatory Science from Project Data Sphere. 

**Board Certifications**  
Dermatology, American Board of Dermatology  
Internal Medicine, American Board of Internal Medicine  
Medical Oncology, American Board of Internal Medicine  

[Dr. Miller's Link to the MGH Cancer Center](https://www.massgeneral.org/doctors/20354/david-miller)  